1.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Glob...
by Abd-Allah, Foad
The Lancet (British edition), 2017-09-16, Vol.390 (10100), p.1211-1259
2.
The burden of disease in older people and implications for health policy and practice
by Prince, Martin J, Prof
The Lancet (British edition), 2015, Vol.385 (9967), p.549-562
3.
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016:...
by Abate, Kalkidan Hassen
The Lancet (British edition), 2017-09-16, Vol.390 (10100), p.1260-1344
4.
Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
by Bauer, Ursula E, PhD
The Lancet (British edition), 2014, Vol.384 (9937), p.45-52
5.
Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease
by Wiegman, Coen H., PhD
Journal of allergy and clinical immunology, 2015, Vol.136 (3), p.769-780
6.
Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study
by Gershon, Andrea S, Dr
The Lancet (British edition), 2011, Vol.378 (9795), p.991-996
7.
Chronic obstructive pulmonary disease
by Decramer, Marc, Prof
The Lancet (British edition), 2012, Vol.379 (9823), p.1341-1351
8.
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
by Suissa, Samy
Thorax, 2012-11, Vol.67 (11), p.957-963
9.
Burden and clinical features of chronic obstructive pulmonary disease (COPD)
by Pauwels, Romain A
The Lancet (British edition), 2004-08-14, Vol.364 (9434), p.613-620
10.
The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease
by Steer, John
Thorax, 2012-11, Vol.67 (11), p.970-976
11.
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes
by Garcia-Aymerich, Judith
Thorax, 2011-05, Vol.66 (5), p.430-11
12.
Asthma in older adults
by Gibson, Peter G, Prof
The Lancet (British edition), 2010, Vol.376 (9743), p.803-813
13.
Determinants and outcomes of physical activity in patients with COPD: a systematic review
by Gimeno-Santos, Elena
Thorax, 2014-08, Vol.69 (8), p.731-9
14.
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
by Romani, Luigina
Nature, 2008-01-10, Vol.451 (7175), p.211-215
15.
Chronic obstructive pulmonary disease
by Rabe, Klaus F, Prof
The Lancet (British edition), 2017, Vol.389 (10082), p.1931-1940
16.
Chronic inflammation in the etiology of disease across the life span
by Furman, David
Nature medicine, 2019-12, Vol.25 (12), p.1822-1832
17.
The burden and costs of chronic diseases in low-income and middle-income countries
by Abegunde, Dele O, MSc
The Lancet (British edition), 2007, Vol.370 (9603), p.1929-1938
18.
Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases
by Conti, Francesca, MD, PhD
Journal of allergy and clinical immunology, 2016, Vol.138 (1), p.241-248.e3
19.
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic anal...
by Degenhardt, Louisa
The Lancet (British edition), 2015, Vol.386 (9995), p.743-800
20.
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlle...
by Martinez, Fernando J, Prof
The Lancet (British edition), 2015, Vol.385 (9971), p.857-866
